"List of resolutions doesnt include commiting to some form of...

"List of resolutions doesnt include commiting to some form of accountability in missed guidance on income and deals."

It does in a way - but not a way that we really want to see - holds no benefit to shareholders but protects those parties under the Convertible Note issue - miss deal guidance & the Special Discount will be 25-40% from market price.

Then again isn't the acountabiliy kind of ironic for those on the board taking part ? Fail on achieving the best possible outcomes & you get a large discount from market price for your stock purchase meet guidance & still get a discount just not quite as big as if you fail.

I still don't really understand the later points in that special discount though - firstly i think that it's fair to assume that if 3 more deals on similar terms to Janssen are reached then the share price will be well above 5.3c so likely 5.3c would be the lesser & therefore issue price however - based on what we've seen this year despite the Janssen deal being formalised the share price is much lower. This special discount really means management need to get a bit more transparent on deals - how ae we to know if deals are reached on similar financial terms to Janssen if nothing is publicly disclosed ? or is the Special Discount meant to be applied on things that they wont realease to market ?

Really need some more transparency on some of these deals & i also like to see time factors - do they fix dates ink to paper when they reach the deals ? are the pharma bound to reach decisions & make moves with in a period - Roche would be a key question approaching 3 years and still thinking about a license ?